Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Clin Cancer Res. 2014 Dec 5;21(5):985–994. doi: 10.1158/1078-0432.CCR-14-1765

Figure 1. ARRY-614 Plasma Concentration-Time Profiles.

Figure 1

(A) Geometric mean concentration-time profile represented from each dose level in the dose escalation phase. (B) Geometric mean concentration-time profile after administration of 400 mg ARRY-614 under both fed and fasted conditions.